• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大唾液腺多形性腺瘤癌变——临床病理综述]

[Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].

作者信息

Stodulski Dominik, Rzepko Robert, Kowalska Bozena, Stankiewicz Czesław

机构信息

Katedra i Klinika Chorób Uszu, Nosa, Gardła i Krtani AM w Gdańsku.

出版信息

Otolaryngol Pol. 2007;61(5):687-93. doi: 10.1016/S0030-6657(07)70507-3.

DOI:10.1016/S0030-6657(07)70507-3
PMID:18552001
Abstract

BACKGROUND

Pleomorphic adenoma (PA) is the most common neoplasm of the major salivary glands. There are three subtypes of malignant PA: carcinoma ex pleomorphic adenoma (CXPA); carcinosarcoma (true malignant mixed tumor) and metastasizing pleomorphic adenoma. The most common subtype of malignant PA is CXPA which develops in primary or recurrent PA. For proper diagnosis of CXPA, a statement of coexistence of pleomorphic adenoma and carcinoma (or carcinoma after prior PA surgery) is needed. Own material is presented because of rarity and clinicopathologic specificity of this neoplasm.

METHODS

Retrospective analysis of the medical data of 19 patients who were treated at our department because of CXPA from 1990 to 2002 was done. The following clinical factors were evaluated: age, sex, symptoms (time of lasting, evolution), tumor size, invasion of the adjacent structures and facial nerve, neck nodes, clinical stage, treatment outcome. One pathologist reviewed histological material of 18 out of 19 patients who had been operated and pathological factors such as sensitivity and accuracy of fine needle aspiration biopsy, grade, histology and proportion of malignant component in tumor, lymph nodes metastases were analyzed.

RESULTS

There were 11 men and 8 women, the mean age was 57 years. In 15 cases, tumor was localized in the parotid and in 4 in the submandibular gland. Two patients had history of prior surgery of PA. Duration of symptoms of benign PA was from 2 to 40 years (mean 17.8 years). Symptoms of malignant transformation occurred in 15 patients, the most common were rapid enlargement of tumor, pain and facial nerve palsy. Tumor size varied from 2 to 20 cm with a mean of 6 cm. In 14 patients, the neck was evaluated clinically as No, in 5, examination identified enlarged lymph nodes. Adjacent structures were invaded by neoplasm in 5 cases. Sensitivity and accuracy of fine needle aspiration biopsy in detection of malignant character of PA were 60% and 46% respectively. 17 out of 18 tumors reviewed by the pathologist were high grade. Only in 6 patients, proportion of carcinoma in the mass was less than 50%. The most common malignant component in CXPA was adenocarcinoma (9 cases) and undifferentiated carcinoma (6 cases). Pathologic examination showed metastases to the lymph nodes in 7 out of 10 patients with prior neck dissection. 16 patients were treated surgically (12 of them had also radiation therapy) and 3 patients underwent only (chemo)radiotherapy. Determinate survival at 5 years was 73.6% and in the group treated surgically (alone or with postoperative irradiation) 87.5%.

CONCLUSIONS

Malignant transformation of PA occurs in 5 to 25% untreated patients, usually after 15-20 years and warning symptoms are present in the most cases. Fine needle aspiration biopsy has insufficient sensibility and accuracy in detection of malignant character of PA. Clinical picture and histopathological examination determinate the diagnosis of CXPA. Proper histological classification of malignant component can be found difficult. Surgical treatment (alone or with postoperative irradiation), if possible, allows to achieve good locoregional control of CXPA. 5-years survival varied between 30 to 76%. The best method of prevention and treatment of CXPA is early and radical removal of all major salivary glands tumors.

摘要

背景

多形性腺瘤(PA)是大唾液腺最常见的肿瘤。恶性PA有三种亚型:多形性腺瘤癌变(CXPA);癌肉瘤(真性恶性混合瘤)和转移性多形性腺瘤。恶性PA最常见的亚型是CXPA,它发生于原发性或复发性PA。为了正确诊断CXPA,需要说明多形性腺瘤与癌并存(或先前PA手术后发生癌)。由于该肿瘤罕见且具有临床病理特异性,故展示自身病例资料。

方法

对1990年至2002年因CXPA在我科接受治疗的19例患者的医疗资料进行回顾性分析。评估以下临床因素:年龄、性别、症状(持续时间、演变过程)、肿瘤大小、对邻近结构及面神经的侵犯、颈部淋巴结情况、临床分期、治疗结果。一名病理学家对19例接受手术治疗患者中的18例的组织学资料进行了复查,并分析了细针穿刺活检的敏感性和准确性、分级、组织学类型以及肿瘤中恶性成分的比例、淋巴结转移情况等病理因素。

结果

男性11例,女性8例,平均年龄57岁。15例肿瘤位于腮腺,4例位于下颌下腺。2例患者有PA既往手术史。良性PA症状持续时间为2至40年(平均17.8年)。15例患者出现恶变症状,最常见的是肿瘤迅速增大、疼痛及面神经麻痹。肿瘤大小为2至20 cm,平均6 cm。14例患者临床评估颈部为阴性,5例检查发现肿大淋巴结。5例肿瘤侵犯邻近结构。细针穿刺活检检测PA恶性特征的敏感性和准确性分别为60%和46%。病理学家复查的18例肿瘤中17例为高级别。仅6例患者肿瘤中癌的比例小于50%。CXPA中最常见的恶性成分是腺癌(9例)和未分化癌(6例)。病理检查显示,10例接受过颈部清扫术的患者中有7例出现淋巴结转移。16例患者接受了手术治疗(其中12例还接受了放疗),3例患者仅接受了(化疗)放疗。5年确定生存率为73.6%,手术治疗组(单独手术或术后放疗)为87.5%。

结论

未治疗的PA患者中5%至25%会发生恶变,通常在15至20年后,大多数病例会出现警示症状。细针穿刺活检检测PA恶性特征的敏感性和准确性不足。临床表现和组织病理学检查决定CXPA的诊断。可能难以对恶性成分进行恰当的组织学分类。手术治疗(单独手术或术后放疗),如果可行,可实现对CXPA良好的局部区域控制。5年生存率在30%至76%之间。预防和治疗CXPA的最佳方法是早期彻底切除所有大唾液腺肿瘤。

相似文献

1
[Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].[大唾液腺多形性腺瘤癌变——临床病理综述]
Otolaryngol Pol. 2007;61(5):687-93. doi: 10.1016/S0030-6657(07)70507-3.
2
[Malignant mixed tumors of the parotid gland: a review of the Department of Otolaryngology Medical University of Warsaw experience].[腮腺恶性混合瘤:华沙医科大学耳鼻喉科经验回顾]
Otolaryngol Pol. 2012 Sep;66(4 Suppl):4-10. doi: 10.1016/S0030-6657(12)70777-1.
3
Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.腮腺多形性腺瘤癌变风险。
JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):1034-1041. doi: 10.1001/jamaoto.2023.3212.
4
Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.低度恶性多形性腺瘤癌:诊断及细针穿刺活检所致的诊断挑战:三例报告并文献复习
Head Neck Pathol. 2018 Mar;12(1):82-88. doi: 10.1007/s12105-017-0829-7. Epub 2017 Jun 6.
5
Own experience in the treatment of major salivary gland tumors.治疗大型唾液腺肿瘤的个人经验。
Otolaryngol Pol. 2020 Feb 5;74(3):17-22. doi: 10.5604/01.3001.0013.6605.
6
Carcinoma ex pleomorphic adenoma: a clinicopathologic review.多形性腺瘤恶变:临床病理回顾
Head Neck. 2001 Sep;23(9):705-12. doi: 10.1002/hed.1100.
7
Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge.涎腺多形性腺瘤恶变的细胞学特征:一项诊断挑战。
Diagn Cytopathol. 2020 Feb;48(2):149-153. doi: 10.1002/dc.24333. Epub 2019 Nov 1.
8
Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.在多形性腺瘤向多形性腺瘤癌变的恶性转化过程中Plag1表达缺失。
Hum Pathol. 2016 Nov;57:152-159. doi: 10.1016/j.humpath.2016.07.011. Epub 2016 Jul 26.
9
Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.多形性腺瘤恶变:73例病例的病理分析
Hum Pathol. 2001 Jun;32(6):596-604. doi: 10.1053/hupa.2001.25000.
10
Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of salivary gland swelling: an institutional experience.细针穿刺细胞学检查(FNAC)在唾液腺肿胀评估中的诊断作用:一项机构经验。
BMC Res Notes. 2015 Mar 27;8:101. doi: 10.1186/s13104-015-1048-5.

引用本文的文献

1
Expression of p16 protein in pleomorphic adenoma and carcinoma ex pleomorphic adenoma proves diversity of tumour biology and predicts clinical course.p16 蛋白在多形性腺瘤和癌在多形性腺瘤中的表达证明了肿瘤生物学的多样性,并预测了临床过程。
J Clin Pathol. 2022 Sep;75(9):605-611. doi: 10.1136/jclinpath-2021-207440. Epub 2021 May 3.
2
Effective chemotherapy for submandibular gland carcinoma ex pleomorphic adenoma with lung metastasis after radiotherapy: A case report.放疗后伴肺转移的多形性腺瘤恶变型下颌下腺癌的有效化疗:1例报告
World J Clin Cases. 2019 Mar 26;7(6):792-797. doi: 10.12998/wjcc.v7.i6.792.
3
Intraosseous pleomorphic adenoma of the mandible.
下颌骨骨内多形性腺瘤
Iran J Radiol. 2015 Jan 1;12(1):e6921. doi: 10.5812/iranjradiol.6921. eCollection 2015 Jan.
4
Carcinoma ex pleomorphic adenoma: Diagnostic dilemma and treatment protocol.多形性腺瘤恶变:诊断困境与治疗方案
Indian J Dent. 2014 Jul;5(3):157-60. doi: 10.4103/0975-962X.140840.